Drug distributor McKesson to buy controlling stake in Core Ventures for about $2.5 billion

(Reuters) – Drug distributor McKesson said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute’s business and administrative services unit, Core Ventures, for $2.49 billion in cash.

(Reporting by Mariam Sunny in Bengaluru; Editing by Shilpi Majumdar)